Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

Published:2002-08 Issue:5 Volume:53 Page:1097-1105
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pollack Alan,Zagars Gunar K,Starkschall George,Antolak John A,Lee J.Jack,Huang Eugene,von Eschenbach Andrew C,Kuban Deborah A,Rosen Isaac

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference36 articles.

1. Advanced prostate cancer;Shipley;Int J Radiat Oncol Biol Phys,1995

2. External beam radiotherapy for stage T1/T2 prostate cancer;Pollack;Urology,1998

3. Dose escalation with 3D conformal treatment;Hanks;Int J Radiat Oncol Biol Phys,1998

4. External beam radiotherapy dose-response characteristics of 1127 men with prostate cancer treated in the PSA era;Pollack;Int J Radiat Oncol Biol Phys,2000

5. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate;Lyons;Urology,2000

Cited by 1221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term evaluation of the safety of a rectal-prostate spacer, the ProSpace® balloon, in patients treated with radiotherapy for prostate cancer;BMC Cancer;2024-08-01

2. Tolérance à court et moyen terme d’une radiothérapie prostatique hypofractionnée selon la technique du boost intégré;Cancer/Radiothérapie;2024-08

3. Moderately Hypofractionated Versus Conventionally Fractionated Volumetric Modulated Arc Therapy for Definitive Treatment of Localised Prostate Cancer;Hong Kong Journal of Radiology;2024-05-20

4. The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy;Scientific Reports;2024-04-05

5. Adjuvant chemotherapy in high-risk prostate cancer;Revisiones en Cáncer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3